Jason Long
Overview
Explore the profile of Jason Long including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Schumacher L, Cooke D, Servais E, Rice D, Sarkaria I, et al.
Ann Thorac Surg
. 2024 Dec;
PMID: 39706508
Objective: With robotic technology's rapid growth and integration, an urgent need to bridge the educational gap in thoracic surgical training has emerged. This document, a result of consensus among a...
2.
3.
A Qualitative Study of Electronic Patient-Reported Outcome Symptom Monitoring After Thoracic Surgery
Boisson-Walsh A, Cox C, OLeary M, Shrestha S, Carr P, Gentry A, et al.
J Surg Res
. 2024 Oct;
303:744-755.
PMID: 39461326
Introduction: Thoracic surgery is a mainstay of therapy for lung cancer and other chronic pulmonary conditions, but recovery is often complicated. Digital health systems can facilitate remote postoperative symptom management...
4.
Greve K, Bailes A, Zhang N, Long J, Aronow B, Mitelpunkt A
Pediatr Phys Ther
. 2024 Oct;
37(1):37-44.
PMID: 39392372
Purpose: To characterize physical therapy (PT) dose for children with cerebral palsy (CP) after multi-level surgery (MLS) and examine variation by ambulatory status and surgical burden. Methods: PT dose (Frequency,...
5.
Lu J, Lee J, Yuan E, Wakefield D, Kanke M, Pruitt D, et al.
Mol Ther Nucleic Acids
. 2024 Oct;
35(4):102335.
PMID: 39380712
Small interfering RNAs (siRNAs) hold considerable therapeutic potential to selectively silence previously "undruggable" disease-associated targets, offering new opportunities to fight human diseases. This therapeutic strategy, however, is limited by the...
6.
Henderson L, Durham D, Gruden J, Pritchard M, Lane L, Long J, et al.
J Natl Cancer Inst
. 2024 Jun;
116(11):1825-1829.
PMID: 38913873
We conducted a cross-sectional, multicenter study to compare the demographics, clinical characteristics, and lung cancer screening results among individuals eligible for lung cancer screening per 2013 vs 2021 US Preventive...
7.
Guo Y, Gao Z, LaGory E, Kristin L, Gupte J, Gong Y, et al.
Hepatol Commun
. 2024 May;
8(5).
PMID: 38696369
Background: Human genetic studies have identified several mitochondrial amidoxime-reducing component 1 (MTARC1) variants as protective against metabolic dysfunction-associated steatotic liver disease. The MTARC1 variants are associated with decreased plasma lipids...
8.
Coder B, Price K, Tewari D, Witmier B, Chapman H, Chroscinski M, et al.
J Med Entomol
. 2024 Apr;
61(4):1086-1090.
PMID: 38686844
Borrelia miyamotoi disease is an emerging tick-borne human illness in the United States caused by Borrelia miyamotoi (Spirochaetales: Spirochaetaceae) bacterium. With Pennsylvania reporting thousands of tick-borne disease cases annually, determining...
9.
Bui J, Hendrickson M, Agala C, Strassle P, Haithcock B, Long J
J Thorac Dis
. 2024 Jan;
15(12):6579-6588.
PMID: 38249932
Background: Esophageal perforation (EP) is a life-threatening emergency requiring emergent surgical intervention. Little is known about potential racial-ethnic disparities among patients with EP. Methods: Hospitalizations of adult (≥18 years old)...
10.
Brumbaugh A, Quirk C, Long J
Skeletal Radiol
. 2024 Jan;
53(8):1661-1662.
PMID: 38240760
No abstract available.